Spindle cells from acquired immune deficiency syndrome-associated Kaposi's sarcoma lesions express telomerase activity directly relating to the RNA levels of fibroblast growth factor-2

International Journal of Cancer

Volumn 127, Issue 10, 2010, Pages 2487-2489

  Barillari, Giovanni ^a,b   Franzese, Ornella ^a   Iovane, André ^a   Ensoli, Barbara ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b National AIDS Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; RNA; TELOMERASE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN EXPRESSION; CELL AGING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; LETTER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SPINDLE CELL; TUMOR VASCULARIZATION; BIOSYNTHESIS; ENZYMOLOGY; GENETICS; METABOLISM; NOTE; PATHOLOGY; SARCOMA; VIROLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; FIBROBLAST GROWTH FACTOR 2; HUMANS; RNA, NEOPLASM; SARCOMA; SARCOMA, KAPOSI; TELOMERASE;

EID: 78049495859     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25268     Document Type: Letter

References (24)

1. Falchetti ML, Mongiardi MP, Fiorenzo P, Petrucci G, Pierconti F, D'Agnano I, D'Alessandris G, Alessandri G, Gelati M, Ricci-Vitiani L, Maira G, Larocca LM, et al. Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts. Int J Cancer 2008; 122: 1236-42.
2. Blackburn EH,. Telomeres and telomerase: their mechanisms of action and the effects of altering their functions. FEBS Lett 2005; 579: 859-62.
3. Hida K, Hida Y, Shindoh M,. Understanding tumor endothelial cell abnormalities to develop ideal anti-angiogenic therapies. Cancer Sci 2008; 99: 459-66.
4. Kurz DJ, Hong Y, Trivier E, Huang HL, Decary S, Zang GH, Luscher TF, Erusalimsky JD,. Fibroblast growth factor-2, but not vascular endothelial growth factor, upregulates telomerase activity in human endothelial cells. Arterioscler Thromb Vasc Biol 2003; 23: 748-54.
5. Trivier E, Kurz DJ, Hong Y, Huang HL, Erusalimsky JD,. Differential regulation of telomerase in endothelial cells by fibroblast growth factor-2 and vascular endothelial growth factor-a: association with replicative life span. Ann NY Acad Sci 2004; 1019: 111-5.
6. Yang J, Nagavarapu U, Relloma K, Sjaastad MD, Moss WC, Passaniti A, Herron GS,. Telomerized human microvasculature is functional in vivo. Nat Biotechnol 2001; 19: 219-24.
7. 1 checkpoint controls in telomerase-immortalized endothelial cells. Cell Cycle 2004; 3: 811-16.
8. Franco S, Segura I, Riese HH, Blasco M,. Decreased B16F10 melanoma growth and impaired vascularisation in telomerase-deficient mice with critically short telomeres. Cancer Res 2002; 62: 552-59.
9. Abdelrahim M, Konduri S, Basha R, Philip PA, Baker CH,. Angiogenesis: an update and potential drug approaches. Int J Oncol 2010; 36: 5-18.
10. Bussolati B, Deambrosis I, Russo S, Deregibus MC, Camussi G,. Altered angiogenesis and survival in human tumor-derived endothelial cells. FASEB J 2003; 17: 1159-61.
11. Falchetti ML, Pierconti F, Casalbore P, Maggiano N, Levi A, Larocca LM, Pallini R,. Glioblastoma induces vascular endothelial cells to express telomerase in vitro. Cancer Res 2003; 63: 3750-54.
12. Pallini R, Pierconti F, Falchetti ML, D'Arcangelo D, Fernandez E, Maira G, D'Ambrosio E, Larocca LM,. Evidence for telomerase involvement in the angiogenesis of astrocytic tumors: expression of human telomerase reverse transcriptase messenger RNA by vascular endothelial cells. J Neurosurg 2001; 94: 961-71.
13. Charalambous C, Hofman FM, Chen TC,. Functional and phenotypic differences between glioblastoma multiforme-derived and normal human brain endothelial cells. J Neurosurg 2005; 102: 699-705.
14. Dudley AC, Klagsbrun M,. Tumor endothelial cells have features of adult stem cells. Cell Cycle 2009; 8: 236-8.
15. Ensoli B, Sgadari C, Barillari G, Sirianni MC, Sturzl M, Monini P,. Biology of Kaposi's sarcoma. Eur J Cancer 2001; 37: 1251-69.
16. Ensoli B, Nakamura S, Salahuddin SZ, Biberfeld P, Larsson L, Beaver B, Wong-Staal F, Gallo RC,. AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science 1989; 243: 223-6.
17. Chen Z, Smith KJ, Skelton HG, Barret TL, Greenway HT, Lo SC,. Telomerase activity in Kaposi's sarcoma, squamous cell carcinoma, and basal cell carcinoma. Exp Biol Med 2001; 226: 753-7.
18. Boshoff C, Schulz TF, Kennedy MM, Graham AK, Fisher C, Thomas A, McGee JO, Weiss RA, O'Leary JJ,. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med 1995; 1: 1274-8.
19. Sturzl M, Blasig C, Schreier A, Neipel F, Hohenadl C, Cornali E, Asherl G, Esser S, Brockmeyer NH, Ekman M, Kaaya EE, Tschachler E, et al. Expression of HHV8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma. Int J Cancer 1997; 72: 68-71.
20. Verma SC, Borah S, Robertson ES,. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus up-regulates transcription of human telomerase reverse transcriptase promoter through interaction with transcription factor Sp1. J Virol 2004; 78: 10348-59.
21. Lebbé C, de Cremoux P, Rybojad M, Costa da Cunha C, Morel P, Calvo F,. Kaposi's sarcoma and new herpesvirus. Lancet 1995; 345: 1180.
22. Monini P, Rotola A, de Lellis L, Corallini A, Secchiero P, Albini A, Benelli R, Parravicini C, Barbanti-Brodano G, Cassai E,. Latent BK infection and Kaposi's sarcoma pathogenesis. Int J Cancer 1996; 66: 717-22.
23. Presta M, Dell'Era P, Mitola S, Moroni E, Ronca R, Rusnati M,. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev 2005; 16: 159-78.
24. Bussolati B, Deambrosis I, Russo S, Deregibus MC, Camussi G,. Altered angiogenesis and survival of human tumor-derived endothelial cells. FASEB J 2003; 17: 1159-61.